MA ceo James moves on
December 21, 2015
Medicines Australia (MA) has
announced the resignation of ceo
Tim James to take effect January
2016.
Thanking James for his strong
contribution to the Australian
medicines industry during what
he termed “a very difficult period
for the sector”, interim chairman
Wes Cook said, “Tim has been
a passionate advocate for the
industry during his tenure as CEO
through a most challenging period
and he departs with our deep
thanks and best wishes.”
Cook highlighted James’
achievements during his tenure
as: negotiating the latest Code
of Conduct and smoothly
implementing its new measures;
bringing MA into the digital and
social media era with a new
website and social platforms;
seeking and supporting recent
developments such as the Industry
Growth Centre, Health Industry
Forum, Innovation Statement, Free
Trade Agreements, and the Medical
Research Future Fund; fostering
improved engagement with patient
organisations including the launch
of the updated edition of the
Working Together Guide.
James said he would make an
announcement about his future
direction “in due course” but in
the meantime plans to spend
more time with his young family
“to whom I owe so much after this
year”.
James’ resignation comes only 14
months from his appointment and
two months after the resignation of
group chairman Martin Cross.
The Board plans to recruit for
James’ replacement in the new
year.
The above article was sent to subscribers in Pharmacy Daily's issue from 21 Dec 15To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 21 Dec 15
